Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Release Oral Formulation of Milrinone
NCT01849094
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Healthy
Heart Failure
Interventions
DRUG:
Milrinone 6mg
DRUG:
milrinone 10mg ER
DRUG:
milrinone 14mg
Sponsor
The Alfred